🚨 ALERT 🚨 (ULM)

The Government’s Joint Committee on Vaccination and Immunisation has published its latest plans which will mean 12 million people aged 50 to 64 are no longer eligible for free vaccines

New official figures have been published that reveal the overwhelming number of people who died from Covid had received three or more shots of mRNA vaccines for the virus.

Pfizer Caught Funnelling $12 Million to Anderson Cooper To Promote mRNA Jabs to Americans:

Geert Vanden Bossche spoke out in early 2021 about the risks of driving viral variants by vaccinating in an pandemic. His predictions have been mostly accurate so far. Stay ahead of the science by listening to our next discussion. Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Coordinated Global Alliance for Vaccines and Immunisation's Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates. Joined by Dr Rob Rennebohm, a pediatrician and pediatric rheumatologist. He is currently largely retired. In 2018 he officially retired from the pediatric rheumatology department at Cleveland Clinic, where he was also the Director of the International Susac Syndrome Consultation Service. Watch more videos at McMillan Research:

#covid #medicine #research

Ongoing excess deaths

Week ending 26 May 2023 (Week 21) 11,111 deaths were registered in England and Wales 262 mentioned novel coronavirus (COVID-19), (2.4% of all deaths). Of the 262 deaths involving COVID-19 64.5% (169 deaths) had this recorded as the underlying cause of death Number of deaths above five-year average Private homes 17.3% above, (472 excess deaths) Hospitals 6.3% above, (282 excess deaths) Care homes 6.7% above, (137 excess deaths) Other settings 15.8% above, (130 excess deaths). The number of deaths registered in the UK 12,528, which was (9.4% above the five-year average) 1,076 excess deaths (282 involved COVID-19).

Similar pattern of excess deaths in many countries around the world ONS, UK, week ending 7 July 2023 (Week 27),

Deaths registered in the UK, 11,147, (2.9% above)

Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination

Department of Cardiology and Cardiovascular Research Institute Basel (ESC Heart Failure, open-access journal of the Heart Failure Association of the European Society of Cardiology) Prospective active surveillance study (Not a retrospective passive surveillance study) Industry independent, instigated by the investigators Aims Incidence and potential mechanisms of oligosymptomatic myocardial injury, following COVID-19 mRNA booster vaccination. Safety net for those already boosted, screening and prevention of complications Methods and Results December 2021 to February 2022 Hospital employees scheduled to undergo mRNA-1273 booster vaccination, assessed for mRNA-1273 vaccination-associated myocardial injury, defined as acute dynamic increase in high-sensitivity cardiac troponin T (hs-cTnT) concentration, above the sex-specific upper-limit of normal on day 3 (48-96h) after vaccination without evidence of an alternative cause. 777 participants Median age 37 years, 69.5% women 40 participants (5.1%) had elevated high-sensitivity cardiac troponin T concentration on day 3 (Taken as above the 99th percentile for age and sex) mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%). One in 35 recipients (2.8%) had vaccine-associated myocardial injury Of the 777, 2 women had chest pain Of these 22 cases with mRNA-1273 vaccine-associated myocardial injury Twenty cases occurred in women Two in men Hs-cTnT-elevations were mild and only temporary. No patient had ECG- changes, none developed major adverse cardiac events within 30 days In the overall booster cohort hs-cTnT concentrations, on day 3 Median 5 ng/L, IQR, 4-6 Matched controls (n=777), 3 ng/L IQR, 3-5 Significantly higher p less than 0.001 (If elevated on day3, given warning, investigations and advice) No MACE (major adverse cardiac events) within 30 days Cases had comparable systemic reactogenicity Concentrations of cytokines and cytokine antagonists were markers quantifying systemic inflammation Lower concentrations GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) induces the development of monocytes, neutrophils, eosinophils, and myeloid and dermal dendritic cells. IFN- λ1(IL-29) a group of anti-viral cytokines, that consists of four IFN-λ molecules Conclusion mRNA-1273 vaccine-associated myocardial injury was more common than previously thought, being mild and transient, and more frequent in women versus men. The possible protective role of IFN-λ1(IL-29) and GM-CSF warrant further studies. Similar Pfizer studies A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons

A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons

NZ Pfizer add

New hope children centre

If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you.